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Background: Melatonin (MLT) has many health implications, therefore it is of valuable importance to develop
specific analytical methods for determination of MLT in the presence of its main contaminant, N-{2-[1-({3-[2-
(acetylamino)ethyl]-5-methoxy-1H-indol-2-yl}methyl)-5-methoxy-1H-indol-3-yl]ethyl}acetamide (10). For development
of these analytical methods, compound 10 had to be prepared in an adequate amount.
Results: Compound 10 was synthesized in six steps starting from 5-methoxyindole-2-carboxylic acid (1). Analytical
performance of the proposed spectrofluorimetric methods was statistically validated with respect to linearity,
accuracy, precision and specificity. The proposed methods were successfully applied for the assay of MLT in
laboratory prepared mixtures containing up to 60 % of compound 10 and in commercial MLT tablets with
recoveries not less than 99.00 %. No interference was observed from common pharmaceutical additives and the
results were favorably compared with those obtained by a reference method.
Conclusions: This work describes simple, sensitive, and reliable second derivative spectrofluorimetric method in
addition to two multivariate calibration methods, principal component regression (PCR) and partial least square
(PLS), for the determination of MLT in the presence of compound 10.
Keywords: Melatonin, Contaminants, Synthesis, Spectrofluorimetry, Commercial preparationsBackground
Melatonin (N-acetyl-5-methoxytryptamine, MLT, Figure 1)
is primarily produced by the pineal gland in the brain with
a marked circadian rhythm normally peaking in the
dark to regulate sleep. MLT acts through activation of
two G-protein-coupled receptors, designated as MT1
and MT2 [1]. In addition, a low-affinity putative MLT* Correspondence: mattia68@hotmail.com
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distribution, and reproduction in any mediumbinding site called MT3 has been recently characterized as
a melatonin-sensitive form of the human enzyme quinine
reductase 2 [2]. MLT has found widespread use in the
treatment of sleep disorders, other effects described in the
literature include its anti- inflammatory, pain modulatory,
antitumor, and antioxidant properties [3-8].
MLT as well as L-tryptophane (Trp) are naturally
occurring indole-based compounds and are sold over-
the-counter as dietary supplement in the United States.
Contaminants in Trp preparations are the etiological
agents for the 1989 outbreak of oesinophilia-myalgia
syndrome (EMS), which affected about 1500 people andCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Structures of melatonin (MLT) and compound 10.
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Administration of 15 mg/day MLT for four weeks to
cancer patients has led to induction of oesinophilia
[10,11]. Accordingly, Williamson et al. [12] investigated
the presence of contaminants structurally related to
those found in contaminated Trp preparations. They
reported the presence of six structural analogues of Trp
contaminants in three different commercial MLT
preparations. Two contaminants were identified to be
hydroxymelatonin isomers with MH+= 249 whereas,
other four contaminants were identified as melatonin-
formaldehyde condensation products with MH+= 477.
Consequently, a tighter control on nutritional supple-
ments sold and used as drugs was recommended.
Compound 10 (Figure 1) is the most abundant regio-
isomer from the four melatonin-formaldehyde condensa-
tion contaminants that were found in the commercial
preparations of MLT [12]. To the best of our knowledge,
a preparative methodology for the synthesis of pure 10
has not reported yet. We therefore report herein a
preparative method for the synthesis of compound 10,
which is required for the development of spectrofluori-
metric methods for determination of MLT in the pres-
ence of compound 10 in commercial MLT preparations.
An evaluation of the literature revealed that only one
HPLC/tandem mass spectrometry (LC/MS/MS) method
has been published for the determination of MLT in the
presence of compound 10 [12]. This method offers a
high degree of specificity, however its sophisticated in-
strumentation and cost factor preclude its use in routine
analysis. Therefore, it was desirable to develop simple
and fast procedures that could be applied in quality con-
trol laboratories for the determination of MLT inpresence of compound 10. Derivative spectrofluorimetry
and multivariate calibration methods such as PCR and
PLS are useful means of resolving two overlapping spec-
tra and eliminating matrix interference in the assay of
two-component mixtures [13,14].
The principal advantages of these methods lie in the
improved sensitivity and selectivity, in addition to the
significant economic advantages over other sophisticated
instrumental techniques such as HPLC/tandem mass
spectrometry.
Experimental
Melting points were determined using a capillary melting
point apparatus (Gallenkamp, Sanyo) and are uncor-
rected. Column chromatography was carried out on sil-
ica gel 60 (0.063–0.200 mm) obtained from Merck. A
Bruker AV-400 spectrometer was used to obtain 1H
NMR (400 MHz) and 13 C NMR (100 MHz) spectra. The
NMR resonances were assigned by means of HH-COSY,
HMQC, and HMBC experiments. EI mass spectra were
determined on a Finnigan MAT 8200 spectrometer. IR
spectra, recorded as ATR, were obtained by using a
Biorad PharmalyzIR FT-IR instrument. Fluorescence
measurements were carried out using a Shimadzu
(Kyoto, Japan) RF-5301 version 3.0 spectrofluorimeter
equipped with a 150 W xenon lamp and 1 cm quartz
cells. The slit width of both the excitation and emission
monochromators was set at 5 nm. The calibration and
linearity of the instrument were frequently checked with
standard quinine sulphate (0.01 μg ml-1). Wavelength
calibration was performed by measuring λexcitation at
279 nm and λemission at 333 nm; no variation in the
wavelength was observed. Elemental analyses were
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of Inorganic Chemistry, University of Würzburg. All
reactions were carried out under an argon atmosphere.
MLT was obtained from Merc Inc, New York, USA. Its
purity is certified to be 99.5%. Methanol and ethyl acet-
ate were of analytical-reagent grade. Commercially avail-
able MLT preparation labeled to contain 3 mg MLT was
purchased from the local market.Synthesis
(5-Methoxy-2,3-dihydro-1H-indol-1-yl)(5-methoxy-1
H-indol-2-yl)methanone (3)
A solution of 5-methoxyindoline (2) (0.94 g, 6.28 mmol) in
dry CH2Cl2 (5 ml) was added to a stirred solution of
5-methoxyindole-2-carboxylic acid (1) (1.2 g, 6.28 mmol)
and ethyl-3-(3-dimethylaminopropyl)carbodiimide hydro-
chloride (EDCIHCl) (1.80 g, 9.42 mmol) in dry CH2Cl2
(15 ml). The reaction mixture was stirred for 18 h at room
temperature, extracted with 5 N hydrochloric acid
(3× 5 ml), washed with water (2 × 10 ml), and dried
(Na2SO4). The organic layer was evaporated in vacuo, and
the residue was recrystallized from isopropanol to yield
1.76 g (87%) of 3 (1.76 g, 87%) as a pale yellow powder mp
234–236°C. FTIR (ATR) ν=3270, 2935, 1604, 1576, 1406,
797 cm-1. 1H NMR (DMSO-d6): δ 3.26 (t, 2 H, J=8.4 Hz,
H-3′), 3.79 (s, 3 H, OCH3), 3.81 (s, 3 H, OCH3), 4.52
(t, 2 H, J=8.4 Hz, H-2´), 6.83 (dd, 1 H, J=8.8, 2.5 Hz,
H-6), 6.93 (d, 1 H, J=2.5 Hz, H-4′), 6.95-6.96 (m, 1 H,
H-6′), 7.04 (s, 1 H, H-3), 7.15 (d, 1 H, J=2.5 Hz, H-4),
7.43 (d, 1 H, J=8.8 Hz, H-7), 8.14 (d, 1 H, J=8.6 Hz,
H-7′), 11.58 (br., 1 H, NH). 13C NMR (DMSO-d6): δ 28.4
(C-3′), 49.7 (C-2′), 55.3 (OCH3), 55.4 (OCH3), 102.1 (C-4),
104.9 (C-3), 110.7 (C-6′), 111.9 (C-6), 113.1 (C-7), 115.1
(C-4′), 117.6 (C-7′), 127.6, 131.2, 131.4, 133.9, 136.9
(ArC), 153.8, 156.1 (C-5, C-5′), 159.5 (O=C). MS (EI):
m/z (%) = 322 (M+, 27), 174 (10), 149 (100), 134 (29). Anal.
Calcd for C19H18N2O3: C, 70.79; H, 5.63; N, 8.69. Found:
C, 70.41; H, 5.61; N, 8.75.(5-Methoxy-1H-indol-1-yl)(5-methoxy-1H-indol-2-yl)
methanone (4)
A mixture of 3 (0.20 g, 0.62 mmol) and 2,3-dichloro-5,
6-dicyanobenzoquinone (DDQ) (0.19 g, 0.68 mmol) was
heated at reflux temperature in ethyl acetate (30 ml)
for 18 h. The reaction mixture was evaporated under
reduced pressure and the residue was purified by silica
gel chromatography (chloroform/methanol/ammonia,
10:1:0.1) to furnish 0.19 g (96%) of 4 as a light red
powder mp 178–179°C and. FTIR (ATR) ν= 3290,
2937, 1625, 1517, 1026, 797 cm-1.1H NMR (CDCl3): δ
3.85 (s, 3 H, OCH3), 3.87 (s, 3 H, OCH3), 6.63 (d, 1 H,
J= 3.8 Hz, H-3′), 6.99 (dd, 1 H, J= 9.1, 2.5 Hz, H-6′),
7.03 (dd, 1 H, J = 8.8, 2.2 Hz, H-6), 7.07 (d, 1 H,J= 2.2 Hz, H-4), 7.08-7.09 (m, 2 H, H-3, H-4′), 7.37
(d, 1 H, J=8.8 Hz, H-7), 7.90 (d, 1 H, J=3.8 Hz, H-2′), 8.37
(d, 1 H, J=9.1 Hz, H-7′), 9.70 (br., 1 H, NH). 13C NMR
(CDCl3): δ 55.7 (2 x OCH3), 102.4 (C-4), 103.7 (C-3′), 108.9
(C-3), 109.6 (C-7), 113.0 (C-6′), 113.4 (C-6), 116.9 (C-7′),
117.7 (C-4′), 127.6 (C-2′), 127.8, 129.2, 130.8, 131.6, 132.5
(ArC), 154.9, 156.7 (C-5, C-5′), 160.8 (O=C). MS (EI): m/z
(%)=320 (M+, 70), 173 (53), 147 (100), 119 (29). Anal.
Calcd for C19H16N2O3: C, 71.24; H, 5.03; N, 8.75. Found: C,
70.95; H, 5.08; N, 8.68.5-Methoxy-1-[(5-methoxy-1H-indol-2-yl)methyl]-1H-indole
(5)
Compound 4 (0.50 g, 156.03 mmol) was dissolved in dry
THF (5 ml) and was added dropwise to a cooled (0°C)
suspension of LiAlH4/AlCl3 in dry diethyl ether (pre-
pared by a slow addition of AlCl3 (0.32 g, 2.41 mmol) to
a suspension LiAlH4 (0.27 g, 7.13 mmol) in dry diethyl
ether (15 ml) at 0°C. The resulting reaction mixture was
stirred at 0°C for one hour and at room temperature for
another one hour. The reaction was quenched by a slow
addition of saturated sodium sulphate solution. The
solids were removed by filtration, washed with chloro-
form (20 ml) and the combined organic phase was dried
(Na2SO4) and evaporated under reduced pressure. The
residue was purified by silica gel chromatography
(chloroform/methanol/ammonia, 10:1:0.1) to produce
0.4 g (83%) of 5 as a light red powder mp 173–174°C.
FTIR (ATR) ν= 3384, 2956, 1622, 1485, 795 cm-1.1H
NMR (CDCl3): δ 3.83 (s, 3 H, OCH3), 3.85 (s, 3 H,
OCH3), 5.26 (s, 2 H, CH2-N), 6.39 (s, 1 H, H-3) 6.49 (d,
1 H, J= 3.3 Hz, H-3′), 6.81 (dd, 1 H, J= 8.8, 2.3 Hz, H-
6′), 6.86 (dd, 1 H, J= 8.8, 2.5 Hz, H-6), 7.01 (d, 1 H,
J= 8.8 Hz, H-7′), 7.04-7.05 (m, 2 H, H-2′, H-4), 7.15 (d,
1 H, J= 2.3 Hz, H-4′), 7.20 (d, 1 H, J= 8.8 Hz, H-7), 7.74
(br., 1 H, NH). 13 C NMR (CDCl3): δ 44.0 (CH2-N), 55.8
(OCH3), 55.9 (OCH3), 101.3 (C-3), 101.6 (C-3′), 102.3
(C-4), 102.8 (C-4′), 110.1 (C-6′), 111.6 (C-6), 112.2,
112.3 (C-7, C-7′), 128.4, 128.5 (ArC), 129.2 (C-2′), 131.4,
131.6, 134.7 (ArC), 154.2 (C-5, C-5′). MS (EI): m/z
(%) = 306 (M+, 35), 160 (100), 147 (23). Anal. Calcd for
C19H18N2O2: C, 74.49; H, 5.92; N, 9.14. Found: C, 74.19;
H, 5.95; N, 8.89.2-{[5-Methoxy-3-(2-nitroethyl)-1H-indol-1-yl]methyl}-5-
methoxy-3-(2-nitroethyl)-1H-indole (8)
A mixture of 5 (0.250 g, 0.82 mmol), 2-nitroethyl acetate
(0.350 g, 2.63 mmol), and tert. butyl catechol (6 mg) in
xylene (20 ml) was heated at reflux temperature for 18 h.
The reaction mixture was evaporated under vacuum and
the residue was purified by silica gel chromatography
(chloroform/methanol, 9:0.5) to yield 0.17 g (46%) of 8
as brown viscous oil. FTIR (ATR) ν= 3421, 2965, 1548,
Table 1 The four level two factor experimental design of
the calibration set mixtures shown as concentrations of
the mixture components in ng ml-1
Mix. No. MLT Compound 10 Mix. No. MLT Compound 10
1 40 10 9 100 10
2 40 20 10 100 20
3 40 40 11 100 40
4 40 50 12 100 50
5 60 10 13 120 10
6 60 20 14 120 20
7 60 40 15 120 40
8 60 50 16 120 50
Darwish and Attia Chemistry Central Journal 2012, 6:36 Page 4 of 11
http://journal.chemistrycentral.com/content/6/1/361212, 795 cm-1. 1H NMR (CDCl3): δ 3.39 (t, 2 H,
J= 7.1 Hz, CH2-CH2-N), 3.44 (t, 2 H, J= 6.8 Hz, CH2-
CH2-N), 3.83 (s, 3 H, OCH3), 3.84 (s, 3 H, OCH3), 4.56
(t, 2 H, J= 6.8 Hz, CH2-CH2-N), 4.61 (t, 2 H, J= 7.1 Hz,
CH2-CH2-N), 5.30 (s, 2 H, CH2-N), 6.81 (dd, 1 H, J= 8.8,
2.3 Hz, ArH), 6.86 (dd, 1 H, J= 8.8, 2.5 Hz, ArH), 6.88 (s,
1 H, H-2′), 6.80 (d, 1 H, J= 2.4 Hz, ArH), 6.98 (d, 1 H,
J= 2.4 Hz, ArH), 7.09 (d, 1 H, J= 8.8 Hz, ArH), 7.14 (d,
1 H, J= 8.8 Hz, ArH), 7.66 (br., 1 H, NH). 13 C NMR
(CDCl3): δ 22.6 (CH2-CH2-N), 23.5 (CH2-CH2-N), 42.0
(CH2-N), 55.9 (OCH3), 56.0 (OCH3), 74.9 (CH2-CH2-N),
75.7 (CH2-CH2-N), 100.0, 100.6, 110.4, 112.1, 112.6,
112.8 (ArCH), 126.7 (C-2′), 109.5 (C-3, C-3′), 128.9,
130.6, 131.9, 132.0, 133.4 (ArC), 154.5, 154.6 (C-5, C-5′).
MS (EI): m/z (%) = 452 (M+, 17), 233 (58), 186 (100).
Anal. Calcd for C23H24N4O6: C, 61.06; H, 5.35; N, 12.38.
Found: C, 60.86; H, 5.24; N, 12.49.
N-{2-[1-({3-[2-(Acetylamino)ethyl]-5-methoxy-1H-indol-
2-yl}methyl)-5-methoxy-1H-indol-3-yl]ethyl}acetamide (10)
A mixture of 8 (0.17 g, 0.38 mmol) and 10% Pd/C
(70 mg) in absolute ethanol (10 ml) was hydrogenated
under 4 mbar pressure in Parr shaker device at ambient
temperature for 18 h. The reaction mixture was filtered
off and the filtrate was evaporated under reduced pres-
sure to furnish 0.15 g of 9 as pale yellow viscous oil.
Crude 9 (0.15 g, 0.38 mmol) was acetylated using acetic
anhydride (0.36 ml, 3.82 mmol) and triethylamine
(0.38 ml, 2.66 mmol) in dry DCM (10 ml) at room
temperature for 18 h. The solvent was evaporated under
vacuum and the residue was purified by silica gel chro-
matography (chloroform/methanol/ammonia, 10:1:0.1)
to yield 0.11 g (63%) of 10 as a beige powder mp 88–
90°C and was FTIR (ATR) ν= 3286, 2924, 1635, 1216,
794 cm-1.1 H NMR (CDCl3): δ 1.76 (s, 3 H, CH3), 1.80
(s, 3 H, CH3), 2.84 (t, 2 H, J= 6.6 Hz, CH2-CH2-N), 2.96
(t, 2 H, J= 6.8 Hz, CH2-CH2-N), 3.39-3.44 (m, 2 H,
CH2-CH2-N), 3.48-3.53 (m, 2 H, CH2-CH2-N), 3.81 (s,
3 H, OCH3), 3.82 (s, 3 H, OCH3), 5.25 (s, 2 H, CH2-N),
5.74 (t, 1 H, J= 5.7 Hz, NH), 5.83 (t, 1 H, J= 5.6 Hz,
NH), 6.78 (dd, 1 H, J= 8.8, 2.3 Hz, ArH), 6.81 (dd, 1 H,
J= 8.8, 2.5 Hz, ArH), 6.87 (s, 1 H, H-2′), 6.99 (d, 2 H,
J= 2.3 Hz, ArH), 7.11 (d, 1 H, J= 8.8 Hz, ArH), 7.14 (d,
1 H, J= 8.8 Hz, ArH), 8.24 (br., 1 H, NH). 13 C NMR
(CDCl3): δ 23.1 (CH3), 23.2 (CH3), 24.3 (CH2-CH2-N),
25.3 (CH2-CH2-N), 39.8 (CH2-CH2-N), 40.2 (CH2-CH2-
N), 41.9 (CH2-N), 55.9 (2 x OCH3), 100.5, 100.9,
(ArCH), 110.1, 110.3 (C-3, C-3′), 111.9, 112.3, 112.4,
112.5 (ArCH), 126.2 (C-2′), 128.5, 128.8, 130.9, 131.4,
131.9 (ArC), 154.1, 154.2 (C-5, C-5′), 170.3 (O=C),
170.5 (O=C). MS (EI): m/z (%) = 476 (M+, 31), 417 (16),
245 (100), 203 (41), 186 (64). Anal. Calcd for
C27H32N4O4: C, 68.05; H, 6.77; N, 11.76. Found: C,
68.37; H, 6.59; N, 11.66.Analysis
Preparation of MLT and compound 10 standard solutions
Stock solutions of MLT (100 μg ml-1) and compound 10
(300 μg ml-1) were prepared by dissolving 10 mg and
30 mg of MLT and compound 10, respectively, in 100 ml
methanol. Appropriate volumes of these stock solutions
were diluted to give working solutions of 4 and 3 μg ml-1for
MLT and compound 10, respectively. Stock and working
solutions were stable for at least two weeks when stored
refrigerated at 4°C.Preparation of MLT tablets sample solutions
Ten tablets were weighed and finely powdered. An
accurately weighed portion of the powder equivalent to
3 mg of MLT was extracted with ethyl acetate and the
extract was filtered. The extract was evaporated and
reconstituted in methanol to obtain final concentration
of 4 μg ml-1 MLT. Aliquots of tablet extract were diluted
with methanol to obtain final concentration of 120 ng ml-1
and the samples were subjected to the analysis according to
the Calibration procedures.Calibration procedures
Second derivative method
Aliquots equivalent to 20–220 ng ml-1 MLT were
accurately transferred from its standard working solution
into separate series of 5-ml volumetric flasks then
completed to volume with methanol. The emission
spectra of the prepared standard solutions were scanned
from 300 to 450 nm using λexcitation at 279 nm and
stored in the computer. The second derivative of stored
emission spectra of MLT were computed with Δλ=10 nm.
The amplitude of the second derivative peak of MLT was
measured at 324.0 nm. The calibration graph was
constructed by relating the peak amplitudes at 324.0 nm to
the corresponding concentrations of MLT and the
regression equation for the data was computed.
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Four level, two factor calibration design [15] was used
for construction of 16 samples of the calibration set by
transferring different volumes of MLT and compound 10
from their standard working solutions into 5-ml
volumetric flasks then completed to volume with
methanol (Table 1).
The emission spectra of the calibration set were
scanned from 300 to 380 nm using λexcitation at 279 nmN
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the PCR and PLS models The cross validation method,
leaving out one sample at a time, was used to select the
optimum number of factors [16]. Given a set of 16 cali-
bration samples, the PCR and PLS calibrations were per-
formed on 15 samples. By using this calibration, the
concentration of the sample left out was predicted. This
process was repeated a total of 16 times until each sam-
ple had been left out once. The predicted concentrations
were then compared with the known concentrations.
The root mean square error of cross validation
(RMSECV) was calculated in the same manner each time
a new factor was added to the model. The maximum
number of factors used to calculate the optimum
RMSECV was selected to be nine. The method described
by Haland and Thomas [17] was used for selecting the
optimum number of factors.
Assay of laboratory prepared mixtures
Aliquots of MLT and compound 10 were transferred from
their standard working solutions into a series of 5-ml
measuring flasks, completed to volume with methanol and
mixed well. For determination of MLT, by the proposed
methods, the Calibration procedures were applied.
Results and discussion
MLT dietary supplement tablets are mainly used in treat-
ment of sleep disorders and are sold over-the-counter. It
was reported that commercial MLT preparations contain
six contaminants; four of them (MLT-formaldehyde
condensation contaminants) are thought to be respon-
sible for induction of oesinophilia when MLT was270 290 310 330 350
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Figure 2 Zero order excitation and emission spectra of 40 ng ml -1 ofadministered in a high dose for long time [10-12]. Com-
pound 10 is the most abundant regio-isomer from these
four formaldehyde condensation contaminants [12]. Daily
value of MLT intake is not established yet and therefore,
it is of sizable importance to develop simple, accurate,
and sensitive methods for the routine analysis of MLT in
the presence of its main contaminant, compound 10.
To develop such analytical methods, a considerable
amount of pure compound 10 was required to be
prepared. Synthesis of the target compound 10 was
carried out according to the synthetic pathway de-
picted in Scheme 1. Thus, the commercially available
5-methoxyindole-2-carboxylic acid (1) was allowed to
react with the nucleophile 5-methoxyindoline (2) [18]
in the presence of coupling reagent ethyl-3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride (EDCI.
HCl) in DCM at room temperature to furnish the amide 3
in good yield. Subsequent oxidation of indoline ring
of 3 was accomplished using 2,3-dichloro-5,6-
dicyanobenzoquinone (DDQ) in ethyl acetate [19] at
reflux temperature to yield the di-indole derivative 4.
Trials to reduce amide bond in 4 using LiAlH4 in
THF or in diethyl ether led to cleavage of the amide
bond. Reduction of the amide bond in compound 4
was successfully achieved using LiAlH4/AlCl3 (3/1)
mixture in THF/diethyl ether solvent system at 0°C
for one hour and then at room temperature for
another one hour. Introduction of the aminoethyl
side chains into positions 3 and 3′ of compound 5 via
adopting our previously reported procedure [20] was
unsuccessful. Briefly, compound 5 was subjected to
Mannich reaction using dimethylamine and formaldehyde370 390 410 430 450
elength (nm)
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MLT and compound 10 in methanol.
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Figure 3 First order derivative emission spectra of 40 ng ml -1 of MLT (–) and compound 10 (. . .) in methanol using λexcitation at 279 nm.
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http://journal.chemistrycentral.com/content/6/1/36in glacial acetic acid produced the Mannich base 6.
Subsequent quaternization of 6 with methyl iodide
followed by substitution with potassium cyanide in the
presence of dicyclohexyl[18]-crown[6] did not yield the
anticipated compound 7 which might be reduced to its
respective diamine derivative that could produce the target
compound 10 upon acetylation. Accordingly, another
strategy was adopted to synthesize 10. Thus, 2-nitroethyl
acetate [21] was reacted with 5 in xylene at reflux
temperature to yield the di-nitro derivative 8 which was
catalytically hydrogenated in Parr shaker device at 4 mbarPe
ak
 a
m
pl
itu
de
Wavelen
324 nm 
Figure 4 Second order derivative emission spectra of 40 ng ml -1 of M
at 279 nm.pressure to furnish compound 9. Acetylation of 9 using
acetic anhydride and triethylamine in DCM produced
the target compound 10. Assigned structures of the
synthesized compounds were characterized by 1H NMR,
13C NMR, and MS spectral data whereas, purity was
determined via microanalyses.
Spectrofluorometric technique affords a higher sensitivity
when compared with chromatographic ones. Both MLTand
compound 10 exhibited native fluorescence in methanol
with λ emission of 333 after excitation at 279 nm showing
great similarity in their emission spectra. This fact hinderedgth (nm) 
LT (–) and compound 10 (. . .) in methanol using λexcitation
Pe
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itu
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Figure 5 Second order derivative emission calibration spectra of MLT in methanol (20-220 ng ml -1 ) using λexcitation at 279 nm.
F3 F4
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http://journal.chemistrycentral.com/content/6/1/36the direct determination of MLT in the presence of
compound 10 (Figure 2).
In order to ascertain whether determination of MLT in
the presence of compound 10 was feasible, the influence
of the variables potentially affecting the fluorescence
intensity or the position of the emission maxima was
studied. The stability of the drug solutions was checked
as a function of the preparation time and pH. The
fluorescence intensity of MLT and compound 10
solutions maintained at 4°C was found not to vary within
two weeks after preparation. Fluorescence intensity and
fluorescence range of MLT and compound 10 were stable
in pH ranges 2.8-11.2 as they are indole derivatives [22].
Also the effect of diluting solvent was checked and it was
found that methanol and ethanol gave higher sensitivity
than water. Fluorescence intensity for both MLT and
compound 10 was stable for at least 2 h.Table 2 Validation report of the proposed second
derivative spectrofluorimetric method for determination
of MLT
Parameters MLT
Linear range (ng ml−1) 20-220
Intercept ± SD 0.28 ± 0.906
Slope± SD 1.001 ± 0.008
Correlation Coefficient 0.9995
LOD (ng ml-1) 2.988Second derivative method
By examining first and second-order derivative curves of
both MLTand compound 10 emission spectra (Δλ=10 nm)
(Figures 3 and 4), it was clear that MLT can be determined
solely by measuring peak amplitude of the second-order
derivative at 324.0 nm where compound 10 gave zero
response (zero- crossing point). The proposed method was
validated according to ICH-guidelines [23] regarding
linearity, sensitivity, accuracy, specificity, repeatability and
reproducibility.LOQ (ng ml-1) 9.055
Accuracya 100.70 ± 1.772
Repeatabilitya 99.81.32 ± 1.799
Intermediate precisiona 100.83 ± 2.445
a corresponding values are average of three determinations ± SD.Linearity and sensitivity A linear correlation was
obtained between peak amplitude of second derivative
spectra at 324 nm and concentrations of MLT in a range
of 20–220 ng ml-1 (Figure 5).The regression equation was:
PMLT ¼ 0:01748C−0:02736 r ¼ 0:9995
Where P is the peak amplitude of the second derivative
spectrum of MLT at 324.0 nm, C is the concentration of
MLT in ng ml-1 and r is the correlation coefficient. LOD
and LOQ were calculated according to the following
equations [23]:
LOD ¼ 3:3 σ=SandLOQ ¼ 10 σ=S
Where, σ is the standard deviation of the intercept of
regression line and S is the slope of regression line of the
calibration curve. All results are shown in Table 2.
Accuracy
The accuracy of the proposed method was tested by
analyzing triplicate samples of MLT solutions. The recovery
% (mean±SD) was 100.70± 1.772. These results revealed
Table 3 Analysis of MLT in commercial tablets by the proposed and reference methods
Method Second derivative method PCR method PLS method Reference method24
Mean± SDa 100.51 ± 2.663 100.99 ± 1.483 100.79 ± 1.479 100.59 ± 3.379
n 5 5 5 5
t test (2.306) 0.041 0.247 0.124 -
F (6.388) 1.610 5.187 5.220 -
a Mean ± standard deviation.
Values in parentheses are theoretical values for t and F at P= 0.05.
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http://journal.chemistrycentral.com/content/6/1/36excellent accuracy (Table 2). The results obtained by
applying the proposed method for determination of MLT
in tablets were statistically compared with those results
obtained by the reference spectrophotometric method [24].
It was concluded that with 95% confidence, there is no
significant difference between them, since the calculated
t and F values are less than the theoretical values [25]
(Table 3).Repeatability and reproducibility
Intra-assay precision was assessed by analyzing varying
concentrations of MLT (40, 60 and 80 ng ml-1) in
triplicate in one assay batch. The inter-assay precision
was assessed by analyzing the same concentrations in
triplicate on 3 successive days (Table 2). The average
Recovery % around 100% and low SD indicates high
accuracy and high precision of the proposed method,
respectively.Specificity
MLT was determined in laboratory prepared mixtures
containing different percentages of compound 10. The
recovery % (mean ± SD) of 101.09 ± 1.701 proved the
high specificity of the proposed method for quantifying
MLT in presence up to 60% of compound 10 (Table 4).
Specificity was also investigated by observing any
possible interferences from excepients in commercial
MLT tablets, such as talc, magnesium stearate, dicalcium
phosphate, and microcrystalline cellulose. These excipients
did not interfere with the proposed method as indicatedTable 4 Determination of MLT in laboratory prepared mixture
the proposed methods
Mix.
No.
% of
compound
10
Concentration
of
MLT(ng ml-1)
Second d
met
Recovery
1 7 80 101
2 20 80 102
3 40 60 99.
4 50 100 102
5 60 40 99.
Mean± SD 101.09 ±from the obtained good recovery values for the analysis of
commercial MLT tablets (Table 3).PCR and PLS chemometric methods
Two chemometric methods – PCR and PLS – were
applied for the determination of MLT in the presence of
compound 10. PCR and PLS methods involve the
decomposition of the experimental data, such as spectro-
fluorimetric data in this case, into systematic variations
(principal components or factors) that explain the
observed variance in data. The purpose of both methods
is to build a calibration model between the concentration
of the analyte under study (MLT in our case) and the
factors of the data matrix. The main difference between
PLS and PCR methods is in the process of the decom-
position of the experimental data. PCR performs the
decomposition of data matrix into principal component
without using the information about the analyte concen-
tration. On the other hand, PLS performs the decompos-
ition using both spectrum data matrix and analyte
concentration [16]. The first step in the determination of
MLT in presence of compound 10 by PCR and PLS
methods, involves constructing the calibration matrix for
the binary mixture. In this study calibration set was
optimized with the aid of the multilevel multifacor
design method [15]. Table 1 shows the composition of
the 16 calibration samples. The emission spectra of these
mixtures were collected and examined, the near zero
fluorescence intensity after 380 nm accounted for the
rejection of this part from the spectra. The selection of
the optimum number of factors for the PCR and PLSs containing different percentages of compound 10 using
erivative
hod
PCR method PLS method
% of MLT Recovery % of MLT Recovery % of MLT
.11 100.45 100.15
.69 101.72 101.43
75 100.06 99.77
.84 100.62 100.32
05 101.57 101.28
1.701 100.88 ± 0725 100.59 ± 0.728
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http://journal.chemistrycentral.com/content/6/1/36methods was a very important pre-construction step: if
the number of factors retained was more than required,
more noise would be added to the data; if the number
retained was too small, meaningful data that could be
necessary for the calibration might be discarded. In this
study, the leave-one out cross-validation method was
used and the RMSECV values of different developed
models were compared. Two factors were found suitable
for both PCR and PLS methods. To validate the
predictive ability of the suggested models, PCR and PLS
methods were employed to predict the concentration of
MLT in five laboratory-prepared mixtures (validation
samples) containing different percentages of compound
10, where satisfactory results were obtained (Table 4).
The predicted concentrations of the validation samples
were plotted against the known concentrations to
determine whether the model accounted for the
concentration variation in the validation set. Plots were
expected to fall on a straight line with a slope of 1 and
zero intercept. MLT, in all samples, lay on a straight line
and the equations of these lines were y = 0.994 x− 0.205
(r = 0.9995) for PCR and y = 0.997 x− 0.205 (r = 0.9995)
for PLS. Both plots had a slope of almost 1 and an
intercept close to zero. The proposed PCR and PLS
methods were successfully used for the determination of
MLT in commercial preparations (Table 3). The results
obtained by applying PCR and PLS methods for
determination of MLT in tablets were statistically
compared with those results obtained by the reference
spectrophotometric method [24]. It was concluded that
with 95% confidence, there is no significant difference
between them, since the calculated t and F values are less
than the theoretical values [25] (Table 3).Conclusion
In this study, simple and sensitive spectrofluorimetric
methods were developed for the analysis of MLT in the
presence of its main contaminant, compound 10. Reviewing
the literature exposed that there are no reports for such
analysis except a sophisticated HPLC/Ms/Ms method.
Accordingly, compound 10 was synthesized in adequate
quantities starting from 5-methoxyindole-2-carboxylic acid
(1) to be used for the development of appropriate
spectrofluorimetric methods for routine analysis of MLT in
commercial preparations. The proposed spectrofluorimetric
methods combine the rapidness and simplicity advantages
of traditional spectrometric methods together with other
important analytical merits, such as sensitivity and
specificity. Moreover, simplicity was illustrated by the
minimum requirement of chemicals and solvents since
methanol was the only organic solvent used in the
procedure. The suggested methods were validated and can
be applied for routine quality control analysis of MLTcommercial tablets without prior separation or interference
from impurities/excipients.
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